Chinese biotech Innovent Biologics, Inc., backed by Singapore’s Temasek Holdings, is seeking to raise US$400 million to US$500 million in an initial public (IPO) offering in Hong Kong.
Temasek-Backed Biotech Firm Innovent Seeks To Raise Up To $500M In HK IPO appeared first on China Money Network.
...This news article comes via China Money Network, who is the copyright owner of this information and news. FintekAsia.com has licensed the rights to this article and any republication or re-distribution in whole or in part of this content is strictly prohibited without the express consent of